BiotechTube

Novel hormonal therapy

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Prostatic Neoplasms

Conditions

Prostatic Neoplasms

Trial Timeline

Oct 4, 2023 → Dec 18, 2024

NCT ID
NCT06072196

About Novel hormonal therapy

Novel hormonal therapy is a pre-clinical stage product being developed by Astellas Pharma for Prostatic Neoplasms. The current trial status is completed. This product is registered under clinical trial identifier NCT06072196. Target conditions include Prostatic Neoplasms.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT06151418Pre-clinicalCompleted
NCT06072196Pre-clinicalCompleted

Competing Products

20 competing products in Prostatic Neoplasms

See all competitors
ProductCompanyStageHype Score
Tadalafil + PlaceboEli LillyPhase 3
77
Placebo + tadalafilEli LillyPhase 3
77
Abemaciclib + Darolutamide + LHRH agonist/antagonistEli LillyPhase 1
33
Tadalafil + Placebo + Alpha1 BlockerEli LillyApproved
85
tadalafil + placeboEli LillyPhase 2
52
Docetaxel + Ifinatamab Deruxtecan + MK-5684 + Abiraterone + Enzalutamide + Rescue MedicationDaiichi SankyoPhase 1/2
41
Enzalutamide + Abiraterone acetateAstellas PharmaPre-clinical
23
Placebo tamsulosin hydrochloride OCAS 0.4 mg + Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg + Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg + tamsulosin hydrochloride OCAS 0.4 mg + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) + tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)Astellas PharmaPhase 3
77
Novel hormonal therapyAstellas PharmaPre-clinical
23
ASP3550Astellas PharmaPhase 2
52
Mirabegron + Placebo + Tamsulosin HydrochlorideAstellas PharmaApproved
85
tamsulosin 0.4mgAstellas PharmaPre-clinical
23
Tamsulosin hydrochloride + Solifenacin succinateAstellas PharmaApproved
85
Enzalutamide + NSAA + LHRHA or Surgical CastrationAstellas PharmaPhase 3
77
enzalutamide + bicalutamideAstellas PharmaPhase 2
52
Tamsulosin OCASAstellas PharmaApproved
85
degarelixAstellas PharmaPhase 2
52
Tamsulosin OCAS + PlaceboAstellas PharmaApproved
85
Tadalafil + PlaceboEli LillyPhase 2
52
TadalafilEli LillyApproved
85

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85